Neuroleptic action of quaternary chlorpromazine and related drugs injected into various brain areas in rats.
D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects* / Q000502:physiology; D001522:Behavior, Animal; D002375:Catalepsy / Q000139:chemically induced; D002552:Cerebral Ventricles / Q000187:drug effects*; D002746:Chlorpromazine / Q000494:pharmacology*; D004298:Dopamine / Q000502:physiology; D006220:Haloperidol / Q000494:pharmacology*; D006624:Hippocampus / Q000187:drug effects*; D006801:Humans; D008297:Male; D051381:Rats; D014149:Tranquilizing Agents / Q000494:pharmacology*
D014149:Tranquilizing Agents; D006220:Haloperidol; D002746:Chlorpromazine; D004298:Dopamine
Arzneimittelforschung. 1965 Feb;15:104-17
14268414
Science. 1967 Aug 18;157(3790):838-41
17842799
Acta Psychiatr Scand Suppl. 1966;191:178-87
4381453
J Pharm Pharmacol. 1966 Sep;18(9):628-30
4381953
J Pharm Pharmacol. 1966 Nov;18(11):752
4382054
J Pharm Pharmacol. 1967 Jul;19(7):483-4
4382645
Psychopharmacologia. 1967;11(2):179-93
4871477
Acta Pharmacol Toxicol (Copenh). 1966;24(2):263-74
5297995
Psychopharmacologia. 1965 May 21;7(6):416-22
5831879
Arch Int Pharmacodyn Ther. 1966 Apr;160(2):492-4
5954044